• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Vet Med Sci . Seroprevalence of antibodies against severe acute respiratory coronavirus 2 (SARS-CoV-2) in household dogs in Japan

tetano

Editor, Senior Moderator
J Vet Med Sci


. 2021 Sep 24.
doi: 10.1292/jvms.21-0338. Online ahead of print.
Seroprevalence of antibodies against severe acute respiratory coronavirus 2 (SARS-CoV-2) in household dogs in Japan


Genta Ito[SUP] 1 [/SUP], Yuko Goto[SUP] 2 [/SUP], Yudai Kuroda[SUP] 3 [/SUP], Park Eunsil[SUP] 3 [/SUP], Ken Reda[SUP] 3 [/SUP], Takehisa Soma[SUP] 4 [/SUP], Yasuyuki Momoi[SUP] 1 [/SUP]



Affiliations

Abstract

We investigated the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among dogs in the Tokyo area via enzyme-linked immunosorbent assay (ELISA) using the spike protein as the target antigen. Plasma samples from 494 household dogs and blood-donor dogs were tested from July 2020 to January 2021. Of these samples, three showed optical densities that were higher than the mean plus two standard deviations of the mean of the negative-control ODs. Of these three samples, only the sample with the highest optical density by ELISA was confirmed positive by virus neutralization testing. The positive dog presented no SARS-CoV-2-related symptoms. The positivity rate of SARS-CoV-2 infections among dogs in the Tokyo area was approximately 0.2%.

Keywords: antibody; coronavirus disease 2019; dog; severe acute respiratory syndrome coronavirus 2
 
Back
Top Bottom